Singapore-registered healthtech company Buymed, which operates a B2B marketplace for pharmaceuticals, has secured $33.5 million in a Series B funding round led by UOB Venture Management, according to regulatory filings.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
